BSAC OPAT Initiative – where are we now?

Mark Gilchrist, Consultant Pharmacist Infectious Diseases, Imperial College Healthcare NHS Trust

OPAT in Scotland – From “Nice to have” to “Must have”

Andrew Seaton, Consultant in Infectious Diseases and General Medicine, NHS Greater Glasgow and Clyde

The National OPAT Service – past, present and future

Eavan Muldoon, National Clinical Lead for OPAT and CIT programmes, HSE, Ireland

Medication Safety on the OPAT Programme – Pharmacy Screening and Interventions

Katie O'Neill, Supervising Pharmacist, TCP Homecare

The OPAT Management Control Centre process explained

Helen McGrath, Clinical Operations Manager MCC, TCP

Intravesical antimicrobial therapy - a role to play?

Jeffrey Harte, Specialist Registrar in Infectious Diseases, St Vincent’s University Hospital in Dublin, Ireland

OPAT across the world, comparing systems

Paul Reidy, Specialist Registrar in Infectious Diseases, St James' Hospital, Dublin

S-OPAT success

Helen Tuite, NUI Galway

No exit: long-term meropenem usage in OPAT

Nick Power, St James' Hospital Dublin

Posters

BSAC OPAT Initiative overview – Where are we now?

Mark Gilchrist, Consultant Pharmacist Infectious Diseases, Imperial College Healthcare NHS Trust

OPAT in Scotland – From “Nice to have” to “Must have”

Andrew Seaton, Consultant in Infectious Diseases and General Medicine, NHS Greater Glasgow and Clyde

Starting up OPAT during the pandemic

Vhairi Bateman, Consultant in Infectious Diseases and Medical Microbiology, NHS Grampian

Challenges of remote and rural OPAT

Mel Munang, NHS Dumfries and Galloway

Adapting to population needs

Claire Mackintosh, Consultant Infectious Disease Physician, NHS Lothian

Moving points in antimicrobial prescribing in OPAT/ COPAT

Lee Stewart, Antimicrobials Pharmacist, South Glasgow Hospitals

S.aureus bacteraemia and OPAT – review of experience in NHS GGC

Fiona Thorburn & Simon Pybus, Greater Glasgow & Clyde

Developing an OPAT cellulitis pathway across NHS Highland

Alison MacDonald, Area Antimicrobial Pharmacist, NHS Highland

Posters

BSAC OPAT Initiative overview – Where are we now?

Mark Gilchrist, Consultant Pharmacist Infectious Diseases, Imperial College Healthcare NHS Trust

Case 1: Ears, nose, heart, bones and brain- bones and brainHow to treat mastoiditis

Neave Kissane Paediatric Infectious Diseases Fellow, Emma Shaw Paediatric Infectious Diseases CNS OPAT Lead & Nuria Martinez-Alier on behalf of Dr Jenny Handforth, Paediatric Consultant Infectious Diseases/Immunology

Case 2: More than skin deep - the price of beauty

Matthew Laundy, St George's University Hospitals NHS Foundation Trust

Case 3: Can you and should you do Cefdericol on OPAT?

Hannah Kershaw, Principal Pharmacist, Royal Free London NHS Foundation Trust

Case 4: Life prolongation at what cost…..An OPAT story

Carolyn Hemsley, Infectious Diseases and Microbiology Consultant, Guy’s & St Thomas’ NHS Foundation

Hospitals without walls?- Experiences of transforming UCLH OPAT into the community?

Florence Taylor, University College London Hospitals NHS Foundation Trust

Needle free bolus administration - administering teicoplanin and ceftriaxone use a closed system

Stephen Hughes, Chelsea & Westminster Hospitals NHS Foundation Trust

Starting an OPAT service in the midst of a pandemic

Ruaridh Buchanan, Consultant in Infectious Diseases & Microbiology & Valerie Lujilibana, OPAT Clinical Nurse Specialist, Barts Health NHS Trust

Challenges of cross disciplinary management in the DGH OPAT setting

Karen Knox, Infection Control/ OPAT Lead for Surrey & Sussex Healthcare NHS Trust

Posters

BSAC OPAT Initiative overview – Where are we now?

Mark Gilchrist, Consultant Pharmacist Infectious Diseases, OPAT service lead, Imperial College, Healthcare NHS Trust & Co-Lead BSAC OPAT Initiative

Presentation 1 - Making inroads so that getting out is easier: OPAT innovations

Helena White, Infectious diseases consultant, Leicester

Presentation 2 - When everything goes Topsy-Turvey

Sue Snape, Consultant in Microbiology and Infectious Diseases, Nottingham University Hospitals

Presentation 3 - Introducing the ACP role into OPAT

Ashleigh Devine, Sheffield

Presentation 4 - Establishing a COVID virtual ward

Liz Wilson, Lead OPAT nurse, Wythenshawe

Presentation 5 - Seeing through the haze of sparseness of evidence: Mycobacterium abscesses prosthetic joint infection

Helena White, Infectious diseases consultant, Leicester & Ryan Hamilton, Clinical Pharmacist, Kettering General Hospital NHS Foundation Trust SLIDES TO FOLLOW

Presentation 6 - Navigating the “wobbles” of long-term anti-fungal therapy

Anna Wild, Specialist Registrar in Infectious Diseases & Microbiology, Nottingham University Hospitals

Presentation 7 - Sheffield case presentation (bacterial)

Katharine Cartwright, Consultant in Infectious Diseases, Sheffield

Presentation 8 - Overcoming OPAT challenges for a LVAD patient with a fungal infection

Ben Freeman & Connie Baker, Wythenshawe Hospital

Posters

IV antibiotics as palliative option

Monica Ivan

A Delayed Hypersensitivity Reaction in OPAT

Kelly Atack

Admissions Avoidance: Treating Diabetic Foot Infections via OPAT

Kelly Atack

Evidence base for OPAT (GPR, NORS, Drug Stability) - Evidence, standards and outcomes: the trinity of successful OPAT

Dr Sanjay Patel, Paediatric infectious diseases and immunology consultant, Southampton Children’s Hospital

Antifungal Therapy in OPAT

Dr Eavan G. Muldoon, Consultant in Infectious Diseases Mater Misericordiae University Hospital National Clinical Lead for OPAT & CIT Programmes

CIT services in the Republic of Ireland

Noreen Curtin, Primary Care Integrated Services Manager, Community Operations, HSE

Outpatient Antimicrobial therapy for Endovascular Aortic Repair Infection; a 5 year retrospective evaluation

Dr Niamh Allen, Specialist Registrar, Beaumont Hospital, Dublin

Baxter

Evidence base for OPAT (GPR, NORS, Drug Stability) - Evidence, standards and outcomes: the trinity of successful OPAT

Elizabeth Wilson - Lead Nurse, OPAT team, Manchester University NHS Foundation Trust

The impact of 24hr infusions on clinical practice

Tim Hills, Lead Pharmacist, Nottingham University Hospital NHS Trust

Necessity is the Mother of Invention

Amanda Bort, OPAT Lead Specialist Nurse, Nottingham University Hospitals NHS Trust

Palliative OPAT at SWFT

Helen Dillon, Consultant in Infectious Diseases & Acute Medicine, South Warwickshire NHS Foundation Trust

Comedones and carbapenems: hydradenitis suppurativa in the OPAT clinic

Ben Rogers, SpR ID & Medical Microbiology, Leicester Royal Infirmary

Evidence, Standards & Outcomes: The trinity of successful OPAT

Andrew Seaton

The deal of the ART

Owen Seddon

Better Care in the Community

Louise Thomas

Hospital at Home

Karen Fitzpatrick

Adverse events during OPAT therapy

Jon Underwood

Keynote lecture - What is new in OPAT and what is the UK initiative focusing on

Conor Jamieson

The development of an OPAT respiratory pathway

Liz Wilson

Teicoplanin – therapeutic drug monitoring, AKI and OPAT

Liz Craig

Antimicrobial Stewardship within a OPAT service

Philip Howard

Cardiome sponsored session : Dalbavancin and OPAT

Malcolm Bain

Community and outcomes: The OPAT Service Directory and National Outcomes Registr

Carolyne Horner

Keynote lecture - What is new in OPAT and what is the UK initiative focusing on

Mark Gilchrist

Management of tuboovarian abscesses on OPAT

James Hatcher

Managing OPAT and Haemadialysis patients

Claire van Nispen tot Pannerden

OPAT at UCH

Sarah Logan

Antimicrobial Stewardship within a OPAT service

Andrew Seaton

Key considerations for paediatric OPAT services

Faye Chappell

Cardiome sponsored session : Dalbavancin and OPAT

John Cunniffe

Community and outcomes: The OPAT Service Directory and National Outcomes Registry

Felicity Drummond

Keynote lecture - What is new in OPAT and what is the UK initiative focusing on

Mark Gilchrist

Management of skin and soft tissue infections via OPAT

Claire Vallance

Oral antibiotics are not always straight forward

Fiona Robb

OPAT management of SAB

Claire Mackintosh

Antimicrobial Stewardship within a OPAT service

Andrew Seaton

Key considerations for paediatric OPAT services

Conor Doherty

Cardiome sponsored session : Dalbavancin and OPAT

Neil Ritchie

Community and outcomes: The OPAT Service Directory and National Outcomes Registry

Felicity Drummond

What is new in OPAT and what is the UK initiative focusing on

Mr Mark Gilchrist

Antimicrobial Stewardship within a OPAT service

Dr Andrew Seaton

Community and outcomes: The OPAT Service Directory and National Outcomes Registry

Dr Carolyne Horner

Where does dalbavancin fit within my hospital?

Dr John Cunniffe